To study the role of Bilvadi taila Nasya kriyakalpa in treatment of patients with Hearing loss as symptom in comparison with Bilvadi taila karnapooran.
Phase 2
Not yet recruiting
- Conditions
- Health Condition 1: H904- Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
- Registration Number
- CTRI/2024/05/067209
- Lead Sponsor
- Dr Pornima Shinde
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age between 44yrs – 64yrs
Both sexes and socioeconomic class.
Patient having sign and symptoms of karnabadhirya mentioned in the classic and modern text having hearing loss between 25 dB to 60 dB on Pure Tone
Audiometry scale will be included.
Exclusion Criteria
Congenital hearing loss.
Conductive and mixed deafness.
Patients suffering from systemic disease DM, HTN.
Below age of 44 yrs and above 64 yrs.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Bilvadi taila's effects on sensorineural hearing loss?
How does Bilvadi taila Nasya compare to standard-of-care treatments for unilateral sensorineural hearing loss?
Are there specific biomarkers that predict response to Bilvadi taila Karnapooran in Karnabadhirya?
What adverse events are associated with Bilvadi taila interventions in hearing loss patients?
What combination therapies or competitor drugs exist for managing H904 sensorineural hearing loss?